Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific: Ascletis, Biogen, Biontech, Coherus, Eisai, Innocare, Junshi, Kazia, MGC, Novavax, Nrx, Olix, Pfizer, Puma, Sensorion, Takeda.